Press releases

Approval should bring a new treatment option to the millions of women who suffer from uterine fibroids.

CABARNET clinical trial to evaluate the benefits of stenting in conjunction with embolic protection to treat carotid artery disease.

"We are very pleased with the enthusiasm with which the TAXUS system has been received, particularly the positive physician feedback," said Jim Tobin, President and Chief Executive Officer

Approval of paclitaxel-eluting coronary stent system marks a breakthrough event for the treatment of cardiovascular disease in the United States.

Kerkrade site will house Company's new distribution center serving European, Japanese and Inter-Continental markets.

A live webcast and replay of the March 3 session will be available.

“We plan to compete vigorously and successfully in the coronary stent market, and we have every intention of becoming, and remaining, the global leader in that market,” said Jim Tobin, President and Chief Executive Officer.

All pending disputes between the companies will be immediately dismissed; companies have also agreed to cross license patents in certain specified technology areas.

Cameron is developing a next-generation implantable cardioverter defibrillator (ICD) for the cardiac rhythm management market.

Represents a first-of-its-kind treatment option in Canada for carotid artery disease